Zinc and thymulin: T-cell maturation and the limits of thymus restoration

The relationship between zinc and immunity is particularly evident in the thymus, where T-lymphocyte precursors acquire a receptor and undergo selection. Here the trace element participates in protein function, cellular signaling, and the metal-dependent peptide thymulin. Restoring peptide activity, increasing cell numbers experimentally, and preventing age-related thymic involution in humans are different tasks. Each has its own measurement and level of evidence.

Zinc deficiency can impair immune function, giving its correction a biological rationale. This does not imply that supplementation beyond adequate nutrition rejuvenates the thymus, that one hormone controls all T-cell selection, or that the most expensive chemical form produces the best clinical outcome. Evaluating these claims requires following the path from coordination chemistry to a controlled trial.

A nonapeptide, a metal, and a biological assay

Thymulin is associated with the historically described serum thymic factor FTS. Its peptide sequence is pGlu–Ala–Lys–Ser–Gln–Gly–Gly–Ser–Asn. The N-terminal pyroglutamyl is a cyclic lactam residue, while C-terminal Asn retains a free carboxyl group. This short chain does not possess the complex quaternary organization of a large protein; its conformations depend on the medium and metal binding.

In the classic Dardenne study, treating FTS with the chelator Chelex 100 removed activity in the rosette assay, while adding zinc salts restored it. The best restoration occurred at a metal:peptide molar ratio of 1:1. Loss of activity after metal removal was therefore not “irreversible.” Certain other salts produced weaker activation; claiming that every other metal is always completely inactive also conflicts with the primary experiment.

This finding establishes metal dependence of the measured biological action. It does not automatically identify a receptor molecule, the number of receptors on every thymocyte, or a universal affinity constant. The rosette assay itself is a functional experimental system rather than a direct count of new T cells in the body. Restoring a signal in a test tube cannot therefore be called proven restoration of the human immune repertoire.

Coordination chemistry requires specifying the medium

Cung and colleagues investigated Zn(II) complexes of the nonapeptide by NMR in dimethyl sulfoxide-d₆ at different metal:peptide ratios. They distinguished a complex containing one ion and two peptides from a 1:1 complex. Their interpretation implicated the Ser4 hydroxyl and the terminal Asn9 carboxylate in the former; Ser8 also participated in the 1:1 complex. The C-terminal carboxylate must not be confused with asparagine’s amide side chain.

Chemical shifts, exchange, and stoichiometry dependence provide structural information, but are not crystallographic proof of a single unchanging geometry in blood plasma. Solvent, pH, concentrations, and competing ligands influence coordination. Exact physiological distances, an obligatory tetrahedral structure, or a universal nanosecond binding interval cannot be added without a specific measurement.

Under ordinary biological conditions zinc remains Zn²⁺ and does not operate like iron or copper in electron-transfer cycles. Its role here is mainly coordinative and structural. Redox changes in ligands, such as metallothionein thiols, can nevertheless alter zinc availability indirectly. An antioxidant effect does not mean that the ion itself neutralizes a radical through a physiological transition between two oxidation states.

The thymus organizes selection, not simply more cells

Bone-marrow precursors enter a thymic microenvironment where Notch signals, IL-7, chemokines, and epithelial-cell contact support the T-cell program. Development proceeds through stages lacking CD4 and CD8, then expressing both coreceptors, and, for the principal αβ lineages, expressing one. DN1–DN4 definitions based on CD44/CD25 are widely used in mice; each marker combination should not be transferred to human stages without qualification.

TCR rearrangement requires the RAG1/RAG2 complex, DNA breaks, and joining. Terminal deoxynucleotidyl transferase, TdT, adds nontemplated nucleotides to segment junctions and uses divalent metals in the polymerization reaction. This does not make TdT an exclusively zinc-dependent enzyme that thymulin necessarily switches on directly. Structural zinc-binding sites in other proteins must be distinguished from polymerases’ catalytic ions.

In the cortex, cTECs present peptides on MHC and support positive selection of cells with suitable recognition. The thymoproteasome containing β5t influences the MHC-I peptide repertoire, while processing for MHC-II uses other proteolytic pathways. In the medulla, mTECs and dendritic cells participate in negative selection and tolerance; AIRE and FEZF2 broaden tissue-antigen presentation. Some cells enter the regulatory lineage and many are eliminated. More surviving cells without assessing specificity and tolerance do not necessarily mean better immunity.

Cells regulate zinc availability

Total tissue zinc, bound zinc, and the small exchangeable pool are different quantities. Most of the metal is protein-bound; free-ion concentration cannot be equated with a serum value or tablet content. Membranes separating the cytosol, endoplasmic reticulum, Golgi apparatus, and lysosomes divide these pools, while transport produces local changes.

The human ZIP/SLC39 family has 14 members, usually increasing cytosolic metal availability through transport from outside the cell or organelles. The ZnT/SLC30 family has 10 members, usually reducing the cytosolic pool by transport outward or into organelles. These are family classifications rather than proof that every member transports only zinc: SLC30A10, for example, is important in manganese transport. The location and direction of an individual transporter matter when interpreting an experiment.

Metallothioneins contain numerous cysteine thiolate ligands and can bind several zinc ions; clusters containing seven ions have been described for well-studied forms. This is a dynamic buffering system rather than an immobile store. Ligand oxidation and exchange with other proteins alter metal availability. General buffering function does not establish a direct “metallothionein → thymulin” route in every epithelial cell’s secretory apparatus.

Zinc structurally stabilizes several factors, including Ikaros, GATA3, BCL11B, and ThPOK. However, FOXN1 belongs to the forkhead family and is not a zinc-finger factor. T-bet should not be categorized as a zinc-finger protein either: it is a T-box factor. Nutritional dependence of immunity does not turn all important transcriptional regulators into direct zinc metalloproteins.

TCR signaling and the hormonal hypothesis are different mechanisms

TCR has no intrinsic tyrosine-kinase activity. Lck phosphorylates ITAMs in the CD3 complex, recruiting ZAP-70 and assembling a LAT/SLP-76 adaptor network. PLCγ1 cleaves PIP₂ into IP₃ and diacylglycerol: the former promotes calcium signaling, the latter activation of relevant kinases. The calmodulin-dependent phosphatase calcineurin changes NFAT phosphorylation and nuclear localization. This is TCR physiology, not an automatically deciphered thymulin receptor.

Yu and colleagues observed rapid zinc influx after TCR triggering, particularly in the subsynaptic compartment; silencing ZIP6 attenuated this response. Greater metal availability accompanied less SHP-1 recruitment and changes in ZAP-70 phosphorylation and calcium signaling. This supports zinc’s role in setting an activation threshold, but does not establish that a daily supplement reproduces the same spatial dynamics in every person.

Kinases use ATP, and many phosphatases are sensitive to metal coordination and the state of catalytic groups. Zinc excess and deficiency can therefore affect different network nodes differently. Inhibiting one phosphatase cannot establish universal beneficial activation of all T cells. Similarly, reports of cAMP, PKA, or calcium in thymulin experiments do not justify assigning it a definitively established Gs receptor and precise affinity values in every tissue.

Age-related involution and experimental regeneration

With age, the functional thymic microenvironment contracts, epithelial cells change, fatty tissue increases, and the output of new naive T cells declines. Sex steroids, precursors, stroma, stress, infections, and damaging treatment influence this process. Nutritional deficiency may worsen it, but involution cannot be reduced to falling plasma zinc alone. The magnitude of age-related changes also depends on whether measurements concern mass, epithelial tissue, imaging, or cellular output.

Bredenkamp and colleagues restored several characteristics of the aged mouse thymus by forcibly increasing FOXN1 in epithelial cells. This is an important experiment involving targeted transcription-factor control, rather than a trial of oral zinc in older people. Similarity of the final result does not make the interventions interchangeable. Organ enlargement following sex-steroid manipulation also does not guarantee full restoration of youthful architecture and selection.

Another study, by Iovino and colleagues, linked recovery after injury and transplantation in mice to extracellular zinc, endothelial-cell GPR39, and BMP4 production. The signal from damaged cells supported restoration of the epithelial microenvironment. Here GPR39 senses a zinc signal; this is not identification of the thymulin receptor. Post-transplant injury differs from ordinary aging, so these findings are not a clinical protocol for preventing involution.

Human trials: benefit depends on initial status

In Prasad and colleagues’ double-blind trial, 50 adults aged 55–87 were randomized to oral zinc gluconate providing 45 mg elemental zinc daily or placebo for 12 months; complete data were available for 49. Infection incidence was the primary outcome, with immune and oxidative measures as secondary outcomes. Infections occurred less often with zinc, and some inflammatory measures also fell. The small sample and recording methods limit generalization. The study does not demonstrate increased thymic parenchyma or justify an 84% rise in active thymulin attributed to it in popular retellings.

Barnett and colleagues enrolled 31 nursing-home residents aged 65 or older with serum zinc below 70 μg/dL. In the double-blind trial, 16 received 30 mg zinc daily and 15 received a 5 mg/day comparator for three months. The primary outcome was change in serum concentration: the difference in mean change was 16% higher in the 30 mg group after adjusting for baseline, p=0.007. Proliferative responses and peripheral T-cell numbers increased, but significant differences disappeared when proliferation was expressed per T-cell number. This supports correcting insufficiency, without proving thymic rejuvenation or benefit in zinc-replete populations.

The negative ZENITH findings are important precisely at this boundary. The overall European project randomized 433 participants, with 387 completing six months; Hodkinson’s immune publication concerns healthy people aged 55–70. Zinc gluconate supplied 15 or 30 mg elemental zinc daily versus placebo. Individual changes in subsets, including transient B-cell reduction and a CD4/CD8 change, did not constitute a significant sustained overall effect on immune status. The project’s total sample must not be presented as the number in each immune analysis. The study does not demonstrate universal thymic regeneration in healthy zinc-replete people.

TRIIM was a small uncontrolled pilot of a combined intervention in men aged 51–65, with nine participants in the final analysis. Growth hormone, DHEA, and metformin were used for a year; accompanying zinc, described in the protocol as 50 mg daily, was not independently randomized. MRI and immune measures changed, while epigenetic-age estimates declined by approximately 1.5 years from baseline, or 2.5 years relative to advancing chronological time. No control group separates the components, natural fluctuations, or analysis characteristics. Such clocks are not direct proof of longer life, fewer infections, or independent zinc efficacy.

What laboratory measurements show

Serum or plasma zinc is useful in the context of nutrition and disease, but depends on inflammation, albumin, sampling time, and food intake. A low value during inflammatory redistribution does not always indicate depletion of all tissue stores. Clinical circumstances, repeatability, and laboratory requirements matter. The related issue of acute-phase markers is discussed in the article on hs-CRP.

Erythrocyte zinc should not be presented as an unconditionally reliable store measurement covering the cell’s entire lifespan. Alkaline phosphatase is a metalloenzyme, but other factors affect its activity, so a single threshold does not diagnose deficiency. Hair analysis is sensitive to contamination and methodology. A copper:zinc ratio also does not replace identifying why each metal has changed.

TRECs are DNA fragments arising during receptor rearrangement; they do not replicate during cell division. Their concentration depends on new thymic output, peripheral proliferation, cell composition, and survival. CD31 and naive-phenotype markers add information, but likewise do not make one test a precise measure of organ age. A functional thymulin assay and immunological peptide detection may capture different forms: in the described enzyme immunoassay, free and zinc-bound peptide had the same immunoreactivity. Understanding the particular method is therefore essential.

Nutrition, formulations, and safety

Meat, seafood, dairy products, legumes, nuts, and seeds can supply zinc, but actual intake and absorption depend on the diet. Phytates bind the metal and may reduce availability; food processing changes phytate content. Poor nutrition, malabsorption, losses, and medication effects require assessment of the cause. The rare inherited ZIP4 disorder causing acrodermatitis enteropathica is not a model for giving similar doses to all older adults.

Labels must distinguish the mass of the salt from elemental zinc. Gluconate, sulfate, citrate, picolinate, and amino-acid complexes differ in composition and tolerability, but absorption comparisons do not prove superiority in preventing thymic involution. Bisglycinate cannot be declared to undergo guaranteed intact absorption through PEPT1 while bypassing every ZIP4 limitation. Zinc-carnosine studied for mucosal indications cannot automatically be transferred to restoration of T-cell output either.

Excess zinc increases copper binding in enterocytes, including through metallothionein, potentially reducing its entry into the body. Prolonged overload may cause copper deficiency with anemia, neutropenia, and neurological problems. The US tolerable upper intake level for adults is 40 mg zinc daily from all sources; this is a population limit for ordinary intake, not a therapeutic dose or a safety guarantee for any course. Medical interventions exceeding it require their own rationale and monitoring.

The trials do not establish a universal rule to add copper at a fixed ratio to any zinc dose. Both metals should be assessed according to indications, rather than compensating for one uncontrolled intake with another. Zinc can interact with tetracyclines, fluoroquinolones, and penicillamine; timing depends on the particular medicine. Polyphenols demonstrating ionophore properties in cell culture do not constitute a validated way to safely bypass cellular regulation in the human thymus. Similar limitations in translating mechanism into treatment are discussed using curcuminoids.

Zinc does connect coordination chemistry, protein structure, and immune signaling. Thymulin makes this connection particularly clear, but does not reduce all immunobiology to one molecule. Justified deficiency correction, experimental regeneration, and proven prevention of age-related involution remain separate claims. The last requires controlled studies measuring thymic output, tolerance, infections, and safety, rather than changes in metal concentration or a laboratory marker alone.